Holen Sie sich die Stockscreener-App
8.79
1.35%
-0.12
Handel nachbörslich:
8.64
-0.15
-1.71%
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Emergent BioSolutions’ Earnings Call Highlights Strong Financial Performance - The Globe and Mail
Emergent BioSolutions’ Strong Q2 Fuels Hopes for 2025 Rally - citybiz
300 new jobs headed to Bayview manufacturing plant - The Business Journals
Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally - Seeking Alpha
Emergent BioSolutions Reports Improved Q2 2025 Results - TipRanks
Published on: 2025-08-10 18:27:00 - metal.it
Earnings Update: Here's Why Analysts Just Lifted Their Emergent BioSolutions Inc. (NYSE:EBS) Price Target To US$13.50 - simplywall.st
Emergent BioSolutions Inc. (NYSE:EBS) Q2 2025 Earnings Call Transcript - Insider Monkey
Emergent Biosolutions (EBS) Q1 Earnings Top Estimates - MSN
Emergent BioSolutions' Strong ROE Amid Industry Average: A Financial Analysis - AInvest
Can Emergent BioSolutions Inc. (NYSE:EBS) Maintain Its Strong Returns? - Yahoo Finance
Emergent BioSolutions to participate in investor conferences in May and June 2025. - AInvest
Benchmark Co. Maintains Emergent BioSolutions(EBS.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Emergent BioSolutions Exceeds Q2 Revenue Guidance, Raises Full-Year Profitability Guidance - AInvest
BioPharma Co.'s $15M Deal Over Ruined J&J Vaccines OK'd - Law360
Emergent BioSolutions Surpasses Q2 Revenue Expectations - The Globe and Mail
Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year - TipRanks
Emergent BioSolutions Soars 22% on Earnings Surprise: What's Fueling the Surge? - AInvest
Emergent Biosolutions reports second quarter loss - Maryland Daily Record
Emergent Biosolutions shares rise 6.14% premarket after securing $51.9 million contract modification for smallpox preparedness. - AInvest
Installed Building Products reports record Q2 2025 results, 3.1% revenue increase. - AInvest
Emergent Biosolutions Q2 Earnings Report: $12 Million LossNews and Statistics - IndexBox
Emergent Biosolutions: Q2 Earnings Snapshot - Huron Daily Tribune
Emergent BioSolutions Inc. SEC 10-Q Report - TradingView
Earnings call transcript: Emergent BioSolutions Q2 2025 results show mixed performance - Investing.com
Emergent BioSolutions Outpaces Its Own Forecasts But Misses Analyst Targets - Finimize
Emergent Biosolutions earnings beat by $0.26, revenue fell short of estimates - Investing.com Canada
Emergent BioSolutions Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Emergent BioSolutions Q2 revenue misses analyst expectations - MarketScreener
Emergent BioSolutions Q2 2025 slides: Profitability improves as transformation continues - Investing.com Canada
Emergent Biosolutions Q2 Earnings: Non-GAAP EPS Beats by $0.65, Revenue Misses by $5.47M - AInvest
Emergent BioSolutions Reports Second Quarter 2025 Financial Results - The Manila Times
Emergent BioSolutions Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
What drives Emergent BioSolutions Inc. stock priceInvest confidently with real-time data analysis - Jammu Links News
Is it the right time to buy Emergent BioSolutions Inc. stockMaximize your portfolio’s growth potential - Jammu Links News
How many analysts rate Emergent BioSolutions Inc. as a “Buy”Strong return on assets - Jammu Links News
What catalysts could drive Emergent BioSolutions Inc. stock higher in 2025Access high-yield investment alerts now - Jammu Links News
Is Emergent BioSolutions Inc. stock overvalued or undervaluedTriple returns potential - Jammu Links News
Why is Emergent BioSolutions Inc. stock attracting strong analyst attentionInvest smarter and grow your wealth faster - Jammu Links News
What are the technical indicators suggesting about Emergent BioSolutions Inc.Stock Market Ideas With Proven Results - Jammu Links News
Insider Sellers Might Regret Selling Emergent BioSolutions Shares at a Lower Price Than Current Market Value - simplywall.st
What institutional investors are buying Emergent BioSolutions Inc. stockPost Market Outlook For Every Investor - Jammu Links News
Why Emergent BioSolutions Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - beatles.ru
Can Emergent BioSolutions Inc. recover in the next quarterReal-Time Analysis With Entry Targets In Progress - metal.it
Emergent BioSolutions Inc. Recovery Hinges on Volume BreakoutPotential Breakout Stock List Published This Week - metal.it
Investors Hope for Bounce in Emergent BioSolutions Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - metal.it
Can Emergent BioSolutions Inc. Regain Momentum After BreakdownCapital Growth With Controlled Risk Picks Suggested - metal.it
Published on: 2025-07-29 03:10:46 - metal.it
Emergent BioSolutions (EBS) Applauds Naloxone Accessibility in U - GuruFocus
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives - The Manila Times
Emergent BioSolutions Commends U.S. House of Representatives for Naloxone Accessibility Initiative - Quiver Quantitative
U.S. House Takes Historic Step: NARCAN Now Available in Every Building to Prevent Opioid Deaths - Stock Titan
What are analysts’ price targets for Emergent BioSolutions Inc. in the next 12 monthsFree Stock Selection - jammulinksnews.com
4.37%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):